Y-27632 2HCl, Inhibitor

Y-27632 2HCl

Cat. Num. AAA385766

• Purity: >98%
• Synonyms: Y-27632 2HCl; inhibitor

• Purity/Purification: >98%
• Form/Format: Powder
• Concentration: 0.1 mM: 31.22 mL (1 mg); 156.1 mL (5 mg); 312.21mL (10 mg); 0.5 mM: 6.24 mL (1 mg); 31.22 mL (5 mg); 62.44 mL (10 mg); 1 mM: 3.12 mL (1 mg); 15.61 mL (5 mg); 31.22 mL (10 mg); 5 mM: 0.62 mL (1 mg); 3.12 mL (5 mg); 6.24 mL (10 mg) (varies by lot)

• CAS Number: 146986-50-7, 129830-38-2
• Formula: C14H21N3O.2HCl
• SMILES: C[C@H](C1CCC(CC1)C(=O)NC2=CC=NC=C2)N.Cl.Cl
• Actions: Inhibitor
• In Vivo Solvent: Saline
• Solubility (DMSO): 64 mg/mL warmed (199.83 mM)
• Solubility (Ethanol): <1 mg/mL (<1 mM)
• Solubility (in vivo): 30 mg/mL
• Solubility (Water): 14 mg/mL (43.71 mM)
• Availability: We cannot ship this item to Switzerland, Italy, Germany, France and Austria.
• Preparation and Storage: at -20 degree C 3 years Powder

Chemical Structure

Related Product Information for Y-27632 2HCl, inhibitor

Y-27632 is a Rho-Associated Coil Kinase (ROCK) inhibitor that increases the cloning efficiency of human embryonic stem cells (hESCs).

References

XinYan, .et al. Establishment of CSUASOi001-A, a non-integrated induced pluripotent stem cell line from urine-derived cells of a Chinese patient carrying RS1 gene mutation, Stem Cell Res, 2019, May 17
Daniela F. Duarte Campos, .et al. Corneal bioprinting utilizing collagen-based bioinks and primary human keratocytes, J Biomed Mater Res A, 2019, April 22
Scott Bell, .et al. Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons, Am J Hum Genet, 2019, May 2;104(5):815-834 PMID: 31031012
Ooi J, .et al. Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects, Cell Rep, 2019, Feb 26;26(9):2494-2508 PMID: 30811996
Scott Bell, .et al. Disruption of GRIN2B Impairs Differentiation in Human Neurons, Stem Cell Reports, 2018, Jul 10; 11(1):183-196 PMID: 29937144
Christina Zarouchlioti, .et al. Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity, Am J Hum Genet, 2018, Apr 5; 102(4): 528-539 PMID: 29526280
Ai Takemoto, .et al. A critical role of platelet TGF-?? release in podoplanin-mediated tumour invasion and metastasis, Sci Rep, 2017, 7: 42186 PMID: 28176852
Scott Bell, .et al. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing, Stem Cells Transl Med, 2017, Mar; 6(3): 886-896 PMID: 28170165